Clinical Trial Update: Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)

View source ↗

Summary

An update on a neoadjuvant peptide receptor radiotherapy trial using Lutetium-177 before liver transplantation for neuroendocrine tumor liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastasis
• Neuroendocrine Tumor

Drugs mentioned

• Lutetium-177 dotatate (Lutetium-177 dotatate)

Snippet

Sponsor: University of Jena | Conditions: Liver, Metastasis | Status: UNKNOWN